Andrew Bauchman

Andrew Bauchman is an accomplished executive with extensive experience in market access, pricing, and contracting within the biopharmaceutical industry. Currently serving as Executive Director of Market Access at Sarepta Therapeutics since July 2020, Bauchman has held senior leadership positions at Portola Pharmaceuticals and Dermira, Inc., focusing on pricing strategies and contract management. A notable career at Pharmacyclics, an AbbVie Company, included various roles from Associate Director to Senior Director in Pricing & Contracting. Bauchman's background also encompasses significant roles at Amgen and experience in the automotive sector with Audi and Nissan. Bauchman holds an MBA in Strategy & Marketing from UCLA Anderson School of Management and a BA in Philosophy from UCLA.